InspireMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	10.85	8.98	7.01	6.21	5.17	4.5
Revenue Growth	54.38%	28.11%	12.96%	20.00%	15.04%	80.88%
Cost of Revenue	7.8	6.33	5.5	4.4	4.05	3.74
Gross Profit	3.04	2.65	1.51	1.81	1.12	0.75
Selling, General & Admin	39.47	37.26	21.38	14.97	12.02	10.31
Research & Development	15.71	15	13.63	7.98	7.81	5.16
Operating Expenses	55.18	52.26	35.01	22.95	19.83	15.47
Operating Income	-52.13	-49.61	-33.5	-21.14	-18.71	-14.72
Interest Expense	-	-	-	-	-	-0.16
Interest & Investment Income	0.89	0.89	1.56	1.29	0.25	-
EBT Excluding Unusual Items	-51.25	-48.72	-31.95	-19.85	-18.46	-14.87
Pretax Income	-51.25	-48.72	-31.95	-19.85	-18.46	-14.87
Income Tax Expense	0.06	0.06	0.06	0.07	0.03	0.05
Net Income	-51.31	-48.79	-32.01	-19.92	-18.49	-14.92
Net Income to Common	-51.31	-48.79	-32.01	-19.92	-18.49	-14.92
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	73	64	42	24	8	7
Shares Outstanding (Diluted)	73	64	42	24	8	7
Shares Change	58.67%	53.42%	72.77%	208.29%	7.16%	385.71%
EPS (Basic)	-0.71	-0.76	-0.76	-0.82	-2.35	-2.03
EPS (Diluted)	-0.71	-0.76	-0.76	-0.82	-2.35	-2.03
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-40.15	-36.77	-23.27	-16.76	-16.02	-13.55
Free Cash Flow Per Share	-0.55	-0.57	-0.56	-0.69	-2.03	-1.84
Gross Margin	28.06%	29.50%	21.49%	29.12%	21.60%	16.77%
Operating Margin	-480.57%	-552.56%	-478.00%	-340.74%	-361.88%	-327.39%
Profit Margin	-472.98%	-543.33%	-456.63%	-320.97%	-357.59%	-331.88%
Free Cash Flow Margin	-370.07%	-409.45%	-332.00%	-270.06%	-309.71%	-301.54%
EBITDA	-51.61	-49.14	-33.22	-20.91	-18.53	-14.56
D&A For EBITDA	0.53	0.48	0.28	0.23	0.19	0.16
EBIT	-52.13	-49.61	-33.5	-21.14	-18.71	-14.72
Advertising Expenses	-	1.6	0.69	0.43	0.36	0.29

SEC Filings: 10-K · 10-Q